Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yue-Long Hou

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Thoracic Cancer|March 18, 2020
Ultrasound location of pulmonary nodules in video-assisted thoracoscopic surgery for precise sublobectomyYue-Long Hou, Yan-Dong Wang, Hong-Qi Guo, et al.
Molecules (Basel, Switzerland)|January 8, 2016
Evaluation of the Nano-TiO2 as a Novel Deswelling MaterialMing Chu, Yue-Long Hou, Lan Xu, et al.
Journal of Atherosclerosis and Thrombosis|April 8, 2016
Intermedin<sub>1-53</sub> Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient MiceJin-Sheng Zhang, Yue-Long Hou, Wei-Wei Lu, et al.
Journal of Hypertension|July 3, 2015
Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinaseWei-Wei Lu, Lei Zhao, Jin-Sheng Zhang, et al.
Chinese Medical Journal|February 28, 2018
Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification RatsYu-Chen Shi, Wei-Wei Lu, Yue-Long Hou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2016
Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative StressWei-Wei Lu, Li-Xin Jia, Xian-Qiang Ni, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 9, 2019
Intermedin<sub>1-53</sub> Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum StressJin-Ling Ren, Yue-Long Hou, Xian-Qiang Ni, et al.
Kidney International|February 17, 2016
Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-KlothoJin Rui Chang, Jun Guo, Yue Wang, et al.
Inflammation|February 17, 2022
Intermedin<sub>1-53</sub> Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac FibrosisLin-Shuang Zhang, Jin-Sheng Zhang, Yue-Long Hou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Thoracic Cancer|March 18, 2020
Ultrasound location of pulmonary nodules in video-assisted thoracoscopic surgery for precise sublobectomyYue-Long Hou, Yan-Dong Wang, Hong-Qi Guo, et al.
Molecules (Basel, Switzerland)|January 8, 2016
Evaluation of the Nano-TiO2 as a Novel Deswelling MaterialMing Chu, Yue-Long Hou, Lan Xu, et al.
Journal of Atherosclerosis and Thrombosis|April 8, 2016
Intermedin<sub>1-53</sub> Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient MiceJin-Sheng Zhang, Yue-Long Hou, Wei-Wei Lu, et al.
Journal of Hypertension|July 3, 2015
Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinaseWei-Wei Lu, Lei Zhao, Jin-Sheng Zhang, et al.
Chinese Medical Journal|February 28, 2018
Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification RatsYu-Chen Shi, Wei-Wei Lu, Yue-Long Hou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2016
Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative StressWei-Wei Lu, Li-Xin Jia, Xian-Qiang Ni, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 9, 2019
Intermedin<sub>1-53</sub> Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum StressJin-Ling Ren, Yue-Long Hou, Xian-Qiang Ni, et al.
Kidney International|February 17, 2016
Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-KlothoJin Rui Chang, Jun Guo, Yue Wang, et al.
Inflammation|February 17, 2022
Intermedin<sub>1-53</sub> Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac FibrosisLin-Shuang Zhang, Jin-Sheng Zhang, Yue-Long Hou, et al.
Pageof 1